# Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation

> **NCT00656266** · PHASE4 · TERMINATED · sponsor: **Baylor College of Medicine** · enrollment: 13 (actual)

## Conditions studied

- End-stage Liver Disease
- Renal Insufficiency
- Renal Failure

## Interventions

- **DRUG:** mycophenolate mofetil
- **OTHER:** placebo medication

## Key facts

- **NCT ID:** NCT00656266
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-11
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** insufficient funding
- **Last updated:** 2020-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00656266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00656266, "Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00656266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*